ID   KCJ12_HUMAN             Reviewed;         433 AA.
AC   Q14500; O43401; Q15756; Q8NG63;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   11-OCT-2005, sequence version 2.
DT   07-APR-2021, entry version 189.
DE   RecName: Full=ATP-sensitive inward rectifier potassium channel 12;
DE   AltName: Full=Inward rectifier K(+) channel Kir2.2;
DE            Short=IRK-2;
DE   AltName: Full=Inward rectifier K(+) channel Kir2.2v;
DE   AltName: Full=Potassium channel, inwardly rectifying subfamily J member 12;
GN   Name=KCNJ12; Synonyms=IRK2, KCNJN1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND SUBCELLULAR LOCATION.
RC   TISSUE=Heart atrium;
RX   PubMed=7859381; DOI=10.1161/01.res.76.3.343;
RA   Wible B.A., de Biasi M., Majumder K., Taglialatela M., Brown A.M.;
RT   "Cloning and functional expression of an inwardly rectifying K+ channel
RT   from human atrium.";
RL   Circ. Res. 76:343-350(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, SUBCELLULAR LOCATION, AND
RP   VARIANT VAL-100.
RX   PubMed=8647284; DOI=10.1016/0014-5793(96)00445-0;
RA   Namba N., Inagaki N., Gonoi T., Seino Y., Seino S.;
RT   "Kir2.2v: a possible negative regulator of the inwardly rectifying K+
RT   channel Kir2.2.";
RL   FEBS Lett. 386:211-214(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], FUNCTION, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12417321; DOI=10.1016/s0014-5793(02)03512-3;
RA   Kaibara M., Ishihara K., Doi Y., Hayashi H., Ehara T., Taniyama K.;
RT   "Identification of human Kir2.2 (KCNJ12) gene encoding functional inward
RT   rectifier potassium channel in both mammalian cells and Xenopus oocytes.";
RL   FEBS Lett. 531:250-254(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 161-433.
RC   TISSUE=Skeletal muscle;
RX   PubMed=9430667; DOI=10.1074/jbc.273.3.1339;
RA   Gallagher P.G., Forget B.G.;
RT   "An alternate promoter directs expression of a truncated, muscle-specific
RT   isoform of the human ankyrin 1 gene.";
RL   J. Biol. Chem. 273:1339-1348(1998).
RN   [6]
RP   INTERACTION WITH KCNJ4.
RX   PubMed=12032359; DOI=10.1073/pnas.102609499;
RA   Preisig-Muller R., Schlichthorl G., Goerge T., Heinen S., Bruggemann A.,
RA   Rajan S., Derst C., Veh R.W., Daut J.;
RT   "Heteromerization of Kir2.x potassium channels contributes to the phenotype
RT   of Andersen's syndrome.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:7774-7779(2002).
RN   [7]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=20921230; DOI=10.1074/jbc.c110.186692;
RA   D'Avanzo N., Cheng W.W., Doyle D.A., Nichols C.G.;
RT   "Direct and specific activation of human inward rectifier K+ channels by
RT   membrane phosphatidylinositol 4,5-bisphosphate.";
RL   J. Biol. Chem. 285:37129-37132(2010).
CC   -!- FUNCTION: Inward rectifying potassium channel that is activated by
CC       phosphatidylinositol 4,5-bisphosphate and that probably participates in
CC       controlling the resting membrane potential in electrically excitable
CC       cells. Probably participates in establishing action potential waveform
CC       and excitability of neuronal and muscle tissues. Inward rectifier
CC       potassium channels are characterized by a greater tendency to allow
CC       potassium to flow into the cell rather than out of it. Their voltage
CC       dependence is regulated by the concentration of extracellular
CC       potassium; as external potassium is raised, the voltage range of the
CC       channel opening shifts to more positive voltages. The inward
CC       rectification is mainly due to the blockage of outward current by
CC       internal magnesium. {ECO:0000269|PubMed:12417321,
CC       ECO:0000269|PubMed:20921230, ECO:0000269|PubMed:7859381,
CC       ECO:0000269|PubMed:8647284}.
CC   -!- SUBUNIT: Association, via its PDZ-recognition domain, with LIN7A,
CC       LIN7B, LIN7C, DLG1, CASK and APBA1 plays a key role in its localization
CC       and trafficking (By similarity). Homotetramer. Forms heteromer with
CC       KCNJ4. {ECO:0000250, ECO:0000269|PubMed:20921230}.
CC   -!- INTERACTION:
CC       Q14500; P50402: EMD; NbExp=3; IntAct=EBI-11794596, EBI-489887;
CC       Q14500; Q14160: SCRIB; NbExp=2; IntAct=EBI-11794596, EBI-357345;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein. Cell
CC       membrane; Multi-pass membrane protein.
CC   -!- DOMAIN: Phosphatidylinositol 4,5-bisphosphate binding to the
CC       cytoplasmic side of the channel triggers a conformation change leading
CC       to channel opening. {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the inward rectifier-type potassium channel (TC
CC       1.A.2.1) family. KCNJ12 subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L36069; AAA65122.1; -; mRNA.
DR   EMBL; U53143; AAC50615.1; -; Genomic_DNA.
DR   EMBL; AB074970; BAC02718.1; -; Genomic_DNA.
DR   EMBL; AB182123; BAD23901.1; -; mRNA.
DR   EMBL; BC027982; AAH27982.1; -; mRNA.
DR   EMBL; AF005214; AAC01951.1; -; mRNA.
DR   CCDS; CCDS11219.1; -.
DR   PIR; I52864; I52864.
DR   PIR; S71341; S71341.
DR   RefSeq; NP_066292.2; NM_021012.4.
DR   RefSeq; XP_005256682.1; XM_005256625.4.
DR   RefSeq; XP_011522133.1; XM_011523831.2.
DR   SMR; Q14500; -.
DR   BioGRID; 109970; 17.
DR   IntAct; Q14500; 3.
DR   MINT; Q14500; -.
DR   STRING; 9606.ENSP00000463778; -.
DR   DrugBank; DB11148; Butamben.
DR   DrugBank; DB00204; Dofetilide.
DR   DrugBank; DB04855; Dronedarone.
DR   DrugBank; DB01110; Miconazole.
DR   DrugBank; DB00243; Ranolazine.
DR   DrugBank; DB01392; Yohimbine.
DR   GuidetoPHARMACOLOGY; 431; -.
DR   TCDB; 1.A.2.1.9; the inward rectifier k(+) channel (irk-c) family.
DR   iPTMnet; Q14500; -.
DR   PhosphoSitePlus; Q14500; -.
DR   BioMuta; KCNJ12; -.
DR   DMDM; 77416868; -.
DR   MassIVE; Q14500; -.
DR   PaxDb; Q14500; -.
DR   PeptideAtlas; Q14500; -.
DR   PRIDE; Q14500; -.
DR   ProteomicsDB; 60008; -.
DR   Antibodypedia; 26154; 224 antibodies.
DR   Ensembl; ENST00000331718; ENSP00000328150; ENSG00000184185.
DR   Ensembl; ENST00000583088; ENSP00000463778; ENSG00000184185.
DR   GeneID; 3768; -.
DR   KEGG; hsa:3768; -.
DR   UCSC; uc002gyv.2; human.
DR   CTD; 3768; -.
DR   DisGeNET; 3768; -.
DR   GeneCards; KCNJ12; -.
DR   HGNC; HGNC:6258; KCNJ12.
DR   HPA; ENSG00000184185; Group enriched (brain, skeletal muscle).
DR   MIM; 602323; gene.
DR   neXtProt; NX_Q14500; -.
DR   OpenTargets; ENSG00000184185; -.
DR   PharmGKB; PA218; -.
DR   VEuPathDB; HostDB:ENSG00000184185.9; -.
DR   eggNOG; KOG3827; Eukaryota.
DR   GeneTree; ENSGT01010000222323; -.
DR   HOGENOM; CLU_022738_3_0_1; -.
DR   InParanoid; Q14500; -.
DR   OMA; DCFMIGA; -.
DR   OrthoDB; 956263at2759; -.
DR   PhylomeDB; Q14500; -.
DR   TreeFam; TF313676; -.
DR   PathwayCommons; Q14500; -.
DR   Reactome; R-HSA-1296041; Activation of G protein gated Potassium channels.
DR   Reactome; R-HSA-1296053; Classical Kir channels.
DR   Reactome; R-HSA-5576886; Phase 4 - resting membrane potential.
DR   Reactome; R-HSA-997272; Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits.
DR   SIGNOR; Q14500; -.
DR   BioGRID-ORCS; 3768; 35 hits in 979 CRISPR screens.
DR   ChiTaRS; KCNJ12; human.
DR   GeneWiki; KCNJ12; -.
DR   GenomeRNAi; 3768; -.
DR   Pharos; Q14500; Tchem.
DR   PRO; PR:Q14500; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q14500; protein.
DR   Bgee; ENSG00000184185; Expressed in muscle of leg and 148 other tissues.
DR   Genevisible; Q14500; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0031224; C:intrinsic component of membrane; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0005242; F:inward rectifier potassium channel activity; IDA:UniProtKB.
DR   GO; GO:0061337; P:cardiac conduction; TAS:Reactome.
DR   GO; GO:0006936; P:muscle contraction; TAS:ProtInc.
DR   GO; GO:1901381; P:positive regulation of potassium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:1990573; P:potassium ion import across plasma membrane; IBA:GO_Central.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; TAS:Reactome.
DR   GO; GO:0006813; P:potassium ion transport; IDA:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; IDA:UniProtKB.
DR   GO; GO:0008016; P:regulation of heart contraction; TAS:ProtInc.
DR   GO; GO:0034765; P:regulation of ion transmembrane transport; IBA:GO_Central.
DR   Gene3D; 2.60.40.1400; -; 1.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR041647; IRK_C.
DR   InterPro; IPR016449; K_chnl_inward-rec_Kir.
DR   InterPro; IPR003272; K_chnl_inward-rec_Kir2.2.
DR   InterPro; IPR013518; K_chnl_inward-rec_Kir_cyto.
DR   InterPro; IPR013673; K_chnl_inward-rec_Kir_N.
DR   InterPro; IPR040445; Kir_TM.
DR   PANTHER; PTHR11767; PTHR11767; 1.
DR   PANTHER; PTHR11767:SF14; PTHR11767:SF14; 1.
DR   Pfam; PF01007; IRK; 1.
DR   Pfam; PF17655; IRK_C; 1.
DR   Pfam; PF08466; IRK_N; 1.
DR   PRINTS; PR01325; KIR22CHANNEL.
DR   PRINTS; PR01320; KIRCHANNEL.
DR   SUPFAM; SSF81296; SSF81296; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Disulfide bond; Ion channel; Ion transport; Membrane;
KW   Potassium; Potassium transport; Reference proteome; S-nitrosylation;
KW   Transmembrane; Transmembrane helix; Transport; Voltage-gated channel.
FT   CHAIN           1..433
FT                   /note="ATP-sensitive inward rectifier potassium channel 12"
FT                   /id="PRO_0000154962"
FT   TOPO_DOM        1..82
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        83..107
FT                   /note="Helical; Name=M1"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        108..123
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        124..128
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        129..141
FT                   /note="Helical; Pore-forming; Name=H5"
FT                   /evidence="ECO:0000250"
FT   INTRAMEM        142..151
FT                   /note="Pore-forming"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        152..156
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250"
FT   TRANSMEM        157..181
FT                   /note="Helical; Name=M2"
FT                   /evidence="ECO:0000250"
FT   TOPO_DOM        182..433
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250"
FT   MOTIF           79..81
FT                   /note="Interaction with phosphatidylinositides"
FT                   /evidence="ECO:0000250"
FT   MOTIF           143..148
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000250"
FT   MOTIF           183..190
FT                   /note="Interaction with phosphatidylinositides"
FT                   /evidence="ECO:0000250"
FT   MOTIF           431..433
FT                   /note="PDZ-binding"
FT                   /evidence="ECO:0000255"
FT   SITE            173
FT                   /note="Role in the control of polyamine-mediated channel
FT                   gating and in the blocking by intracellular magnesium"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         75
FT                   /note="S-nitrosocysteine"
FT                   /evidence="ECO:0000250|UniProtKB:P63252"
FT   DISULFID        155
FT                   /note="Interchain"
FT                   /evidence="ECO:0000250"
FT   VARIANT         6
FT                   /note="R -> Q (in dbSNP:rs3752032)"
FT                   /id="VAR_024509"
FT   VARIANT         15
FT                   /note="S -> L (in dbSNP:rs1657738)"
FT                   /id="VAR_049671"
FT   VARIANT         100
FT                   /note="I -> V (in dbSNP:rs8076599)"
FT                   /evidence="ECO:0000269|PubMed:8647284"
FT                   /id="VAR_059365"
FT   VARIANT         118
FT                   /note="R -> Q (in dbSNP:rs1657740)"
FT                   /id="VAR_059366"
FT   VARIANT         156
FT                   /note="P -> L (in dbSNP:rs1714864)"
FT                   /id="VAR_049672"
FT   VARIANT         192
FT                   /note="Q -> H (in dbSNP:rs1657742)"
FT                   /id="VAR_059367"
FT   VARIANT         249
FT                   /note="I -> V (in dbSNP:rs4985866)"
FT                   /id="VAR_049673"
FT   VARIANT         430
FT                   /note="E -> G (in dbSNP:rs5021699)"
FT                   /id="VAR_059368"
FT   CONFLICT        43
FT                   /note="R -> H (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        71
FT                   /note="M -> I (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        139
FT                   /note="E -> K (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        142
FT                   /note="T -> N (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        145
FT                   /note="G -> S (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        173
FT                   /note="D -> N (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        184
FT                   /note="M -> V (in Ref. 5; AAC01951)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        185
FT                   /note="A -> V (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        211
FT                   /note="L -> F (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        239
FT                   /note="E -> K (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        261..262
FT                   /note="RI -> HS (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        285
FT                   /note="Missing (in Ref. 1; AAA65122)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        289..290
FT                   /note="ET -> QM (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        297
FT                   /note="V -> I (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        302
FT                   /note="M -> I (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        334
FT                   /note="Missing (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        335
FT                   /note="Missing (in Ref. 5; AAC01951)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        343
FT                   /note="S -> L (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        371
FT                   /note="S -> R (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        378
FT                   /note="E -> K (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        402
FT                   /note="D -> E (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        405
FT                   /note="S -> I (in Ref. 2; AAC50615)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   433 AA;  49001 MW;  082027A1765B6F4E CRC64;
     MTAASRANPY SIVSSEEDGL HLVTMSGANG FGNGKVHTRR RCRNRFVKKN GQCNIEFANM
     DEKSQRYLAD MFTTCVDIRW RYMLLIFSLA FLASWLLFGI IFWVIAVAHG DLEPAEGRGR
     TPCVMQVHGF MAAFLFSIET QTTIGYGLRC VTEECPVAVF MVVAQSIVGC IIDSFMIGAI
     MAKMARPKKR AQTLLFSHNA VVALRDGKLC LMWRVGNLRK SHIVEAHVRA QLIKPRVTEE
     GEYIPLDQID IDVGFDKGLD RIFLVSPITI LHEIDEASPL FGISRQDLET DDFEIVVILE
     GMVEATAMTT QARSSYLANE ILWGHRFEPV LFEEKNQYKI DYSHFHKTYE VPSTPRCSAK
     DLVENKFLLP SANSFCYENE LAFLSRDEED EADGDQDGRS RDGLSPQARH DFDRLQAGGG
     VLEQRPYRRE SEI
//
